# EDGAR Filing Document

**Accession Number:** 0000889348
**File Stem:** 0001999371-25-017728
**Filing Date:** 2025-11
**Character Count:** 130585
**Document Hash:** dc13082012b5e114c648f126da1a205c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001999371-25-017728.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001999371-25-017728

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 67

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CPI AEROSTRUCTURES INC
- **CENTRAL INDEX KEY:** 0000889348
- **STANDARD INDUSTRIAL CLASSIFICATION:** AIRCRAFT PART & AUXILIARY EQUIPMENT, NEC [3728]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 112520310
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11398
- **FILM NUMBER:** 251480745

**BUSINESS ADDRESS:**
- **STREET 1:** 200A EXECUTIVE DR
- **CITY:** EDGEWOOD
- **STATE:** NY
- **ZIP:** 11717
- **BUSINESS PHONE:** 5165865200

**MAIL ADDRESS:**
- **STREET 1:** 91 HEARTLAND BLVD
- **CITY:** EDGEWOOD
- **STATE:** NY
- **ZIP:** 11717

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 10-Q**

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the quarterly period ended September 30, 2025

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from ___________ to __________

Commission File Number: **1-11398**

![](cpi10q093025001.jpg)

**CPI AEROSTRUCTURES, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **New York** | **11-2520310** |
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification Number) |

---

---

| | |
|:---|:---|
| **91 Heartland Blvd., Edgewood, NY** | **11717** |
| (Address of principal executive offices) | (Zip code) |

---

**(631) 586-5200**

(Registrant's telephone number including area code)

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Common stock, $0.001 par value per share | CVU | NYSE American |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 12, 2025, the registrant had 13,185,249 shares of common stock, $.001 par value, outstanding

---

| | |
|:---|:---|
| **INDEX** | **INDEX** |
| [**Part I - Financial Information**](#cpi10qa001) | 1 |
| [Item 1 – Consolidated Financial Statements (Unaudited)](#cpi10qa002) | 1 |
| [Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024](#cpi10qa003) | 1 |
| [Condensed Consolidated Statements of Operations for the Three and Nine months ended September 30, 2025 and 2024 (Unaudited)](#cpi10qa004) | 2 |
| [Condensed Consolidated Statements of Shareholders' Equity for the Three and Nine months ended September 30, 2025 and 2024 (Unaudited)](#cpi10qa005) | 3 |
| [Condensed Consolidated Statements of Cash Flows for the Nine months ended September 30, 2025 and 2024 (Unaudited)](#cpi10qa006) | 4 |
| [Notes to Condensed Consolidated Financial Statements (Unaudited)](#cpi10qa007) | 5 |
| [Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations](#cpi10qa008) | 14 |
| [Item 3 – Quantitative and Qualitative Disclosures About Market Risk](#cpi10qa009) | 20 |
| [Item 4 – Controls and Procedures](#cpi10qa010) | 20 |
| [**Part II - Other Information**](#cpi10qa011) | 22 |
| [Item 1 – Legal Proceedings](#cpi10qa012) | 22 |
| [Item 1A – Risk Factors](#cpi10qa013) | 22 |
| [Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds](#cpi10qa014) | 22 |
| [Item 3 – Defaults Upon Senior Securities](#cpi10qa015) | 22 |
| [Item 4 – Mine Safety Disclosures](#cpi10qa016) | 22 |
| [Item 5 – Other Information](#cpi10qa017) | 22 |
| [Item 6 – Exhibits](#cpi10qa018) | 22 |
| [Signatures](#cpi10qa019) | 23 |

---

**Part I - Financial Information**

**Item 1 - Consolidated Financial** 

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **September 30, 2025<br> (Unaudited)** | **December 31,<br> 2024** |
| **ASSETS** |  |  |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $546591 | $5490963 |
| &nbsp;&nbsp;&nbsp;Accounts receivable, net | 6399594 | 3716378 |
| &nbsp;&nbsp;&nbsp;Contract assets, net | 33695994 | 32832290 |
| &nbsp;&nbsp;&nbsp;Inventory | 593605 | 918288 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 552585 | 634534 |
| **Total Current Assets** | 41788369 | 43592453 |
| Operating lease right-of-use assets | 9871784 | 2856200 |
| Property and equipment, net | 565542 | 767904 |
| Deferred tax asset, net | 19918449 | 18837576 |
| Goodwill | 1784254 | 1784254 |
| Other assets | 127624 | 143615 |
| **Total Assets** | $74056022 | $67982002 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $16487974 | $11097685 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 4449051 | 7922316 |
| &nbsp;&nbsp;&nbsp;Contract liabilities | 1992910 | 2430663 |
| &nbsp;&nbsp;&nbsp;Loss reserve | 95082 | 22832 |
| &nbsp;&nbsp;&nbsp;Current portion of line of credit | 1500000 | 2750000 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 5449 | 26483 |
| &nbsp;&nbsp;&nbsp;Operating lease liabilities, current | 1400596 | 2162154 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 21253 | 58209 |
| **Total Current Liabilities** | 25952315 | 26470342 |
| Line of credit, net of current portion | 14390000 | 14640000 |
| Long-term operating lease liabilities | 8724638 | 938418 |
| **Total Liabilities** | 49066953 | 42048760 |
| Commitments and Contingencies (see note 11) |  |  |
| **Shareholders' Equity:** |  |  |
| &nbsp;&nbsp;&nbsp;Common stock - $.001 par value; authorized 50,000,000 shares, 12,988,814 and 12,978,741 shares, respectively, issued and outstanding | 12989 | 12979 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 75015659 | 74424651 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (50039579) | (48504388) |
| **Total Shareholders' Equity** | 24989069 | 25933242 |
| **Total Liabilities and Shareholders' Equity** | $74056022 | $67982002 |

---

See Notes to Condensed Consolidated Financial Statements

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months Ended** <br>**September 30,**  | **For the Three Months Ended** <br>**September 30,**  | **For the Nine Months Ended<br> September 30,** | **For the Nine Months Ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue | $19269102 | $19419879 | $49848818 | $59311356 |
| Cost of sales | 14962788 | 15200210 | 43229647 | 46422514 |
| Gross profit | 4306314 | 4219669 | 6619171 | 12888842 |
| Selling, general and administrative expenses | 2551355 | 2742036 | 8041156 | 8231875 |
| Income (loss) from operations | 1754959 | 1477633 | (1421985) | 4656967 |
| Other income |  |  | 6980 |  |
| Interest expense | (387922) | (573366) | (1163559) | (1793472) |
| Income (loss) before provision for income taxes | 1367037 | 904267 | (2578564) | 2863495 |
| Provision (benefit) provision for income taxes | 253345 | 154590 | (1043373) | 535634 |
| Net Income (loss) | $1113692 | $749677 | $(1535191) | $2327861 |
| Income (loss) per common share, basic | $0.09 | $0.06 | $(0.12) | $0.19 |
| Income (loss) per common share, diluted | $0.09 | $0.06 | $(0.12) | $0.18 |
| <u>Shares used in computing income per common share:</u> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 12763486 | 12647023 | 12740097 | 12559876 |
| &nbsp;&nbsp;&nbsp;Diluted | 12818191 | 12717128 | 12740097 | 12650340 |

---

See Notes to Condensed Consolidated Financial Statements

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common <br> Stock <br> Shares** | **Common <br> Stock <br> Amount** | **Additional <br> Paid-in <br> Capital** | **Accumulated <br> Deficit** | **Total <br> Shareholders'<br> Equity** |
| Balance at January 1, 2025 | 12978741 | $12979 | $74424651 | $(48504388) | $25933242 |
| Net loss |  |  |  | (1323924) | (1323924) |
| Issuance of common stock upon settlement of restricted stock, net | 30553 | 30 |  |  | 30 |
| Stock-based compensation expense |  |  | 320199 |  | 320199 |
| Balance at March 31, 2025 | 13009294 | $13009 | $74744850 | $(49828312) | $24929547 |
| Net loss |  |  |  | (1324959) | (1324959) |
| Issuance of common stock upon settlement of restricted stock, net | (31035) | (31) |  |  | (31) |
| Stock-based compensation expense |  |  | 168614 |  | 168614 |
| Balance at June 30, 2025 | 12978259 | $12978 | $74913464 | $(51153271) | $23773171 |
| Net income |  |  |  | 1113692 | 1113692 |
| Issuance of common stock upon settlement of restricted stock, net | 10555 | 11 |  |  | 11 |
| Stock-based compensation expense |  |  | 102195 |  | 102195 |
| Balance at September 30, 2025 | 12988814 | $12989 | $75015659 | $(50039579) | $24989069 |
| Balance at January 1, 2024 | 12771434 | $12771 | $73872679 | $(51803722) | $22081728 |
| Net income |  |  |  | 168238 | 168238 |
| Issuance of common stock upon settlement of restricted stock, net | 13334 | 13 |  |  | 13 |
| Stock-based compensation expense |  |  | 281510 |  | 281510 |
| Balance at March 31, 2024 | 12784768 | $12784 | $74154189 | $(51635484) | $22531489 |
| Net income |  |  |  | 1409946 | 1409946 |
| Issuance of common stock upon settlement of restricted stock, net | 178095 | 179 |  |  | 179 |
| Stock-based compensation expense |  |  | 175356 |  | 175356 |
| Balance at June 30, 2024 | 12962863 | $12963 | $74329545 | $(50225538) | $24116970 |
| Net income |  |  |  | 749677 | 749677 |
| Issuance of common stock upon settlement of restricted stock, net | (29455) | (30) |  |  | (30) |
| Stock-based compensation expense |  |  | 72743 |  | 72743 |
| Balance at September 30, 2024 | 12933408 | $12933 | $74402288 | $(49475861) | $24939360 |

---

See Notes to Condensed Consolidated Financial Statements

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months ended <br> September 30,** | **For the Nine Months ended <br> September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net (loss) income | $(1535191) | $2327861 |
| Adjustments to reconcile net (loss) income to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 266262 | 305260 |
| &nbsp;&nbsp;&nbsp;Amortization of debt issuance cost | 15991 | 38697 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 591018 | 529771 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | (1080873) | 512717 |
| &nbsp;&nbsp;&nbsp;Provision for credit losses | (86814) | 144565 |
| &nbsp;&nbsp;&nbsp;Amortization of operating lease right-of-use assets | 1175052 | 1405201 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in accounts receivable | (2596402) | (2367222) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in contract assets | (863704) | 1693097 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in inventory | 324683 | 384361 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in prepaid expenses and other assets | 81949 | 300168 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in accounts payable and accrued expenses | 2170637 | 236130 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in contract liabilities | (437753) | (4547502) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in operating lease liabilities | (1165974) | (1486359) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in loss reserve | 72250 | (312463) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in income taxes payable | (36956) | (1359) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in operating activities** | (3105825) | (837077) |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (63900) | (330282) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities** | (63900) | (330282) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Principal payments on line of credit | (1500000) | (1920000) |
| &nbsp;&nbsp;&nbsp;Principal payments on long-term debt | (21034) | (36917) |
| &nbsp;&nbsp;&nbsp;Repayments of insurance financing obligation | (253613) | (261531) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in financing activities** | (1774647) | (2218448) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net decrease in cash | (4944372) | (3385807) |
| Cash at beginning of period | 5490963 | 5094794 |
| Cash at end of period | $546591 | $1708987 |
| **Supplemental disclosures of cash flow information:** |  |  |
| Cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp;Interest | $1258054 | $1795495 |
| &nbsp;&nbsp;&nbsp;Income Taxes | $75933 | $36457 |
| **Supplemental disclosure Non-Cash item:** |  |  |
| &nbsp;&nbsp;&nbsp;Increase to operating right-of-use asset and operating lease liability from lease amendment | $8190636 | $— |

---

See Notes to Condensed Consolidated Financial Statements

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **INTERIM FINANCIAL STATEMENTS** 

**Basis of Presentation**

The Company consists of CPI Aerostructures, Inc. ("CPI Aero"), Welding Metallurgy, Inc. ("WMI"), a wholly owned subsidiary of CPI Aero, and Compac Development Corporation, a wholly owned subsidiary of WMI (collectively, the "Company", "we", "us", or "our").

The condensed consolidated interim financial statements of the Company as of September 30, 2025 and for the three and nine months ended September 30, 2025 and 2024 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and notes normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") have been condensed or omitted pursuant to those rules and regulations. The consolidated balance sheet at December 31, 2024 has been derived from audited consolidated financial statements, but does not include all of the information and notes required by U.S. GAAP. The Company believes that the disclosures are adequate to make the information presented not misleading.

All adjustments that, in the opinion of the management, are necessary for a fair presentation for the periods presented have been reflected. Such adjustments are of a normal, recurring nature. It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"). The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the "CODM") to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company's CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company has determined that it has a single operating and reportable segment.

The Company maintains its cash in multiple financial institutions. The balances are insured by the Federal Deposit Insurance Corporation. From time to time, the Company's balances may exceed insurance limits. As of September 30, 2025, the Company had $334,493 of uninsured balances. The Company limits its credit risk by selecting financial institutions considered to be highly creditworthy.

**Recently Issued Accounting Standards – Adopted**

In 2025, the Company adopted ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. The updated accounting guidance requires expanded income tax disclosures, including the disaggregation of existing disclosures related to the effective tax rate reconciliation and income taxes paid. The guidance is effective for fiscal years beginning after December 15, 2024. An entity may apply the amendments in this ASU prospectively, but an election to treat this retrospectively is permitted. The Company has adopted this ASU, which is expected to impact the annual disclosure in its 10-K.

**Recently Issued Accounting Standards – Not Adopted**

In September 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) No. 2025-06*, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software* ("ASU 2025-06"). This guidance removes all references to prospective and sequential stages (referred to as "project stages") throughout ASC 350-40 and clarifies the threshold entities apply to begin capitalizing costs. Under ASU 2025-06, cost capitalization should only commence when both management has authorized and committed to funding a software project and it is probable the project will be completed and the software will be used to perform the function intended. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027 and interim reporting periods within those annual reporting periods. Entities may apply the guidance using a prospective, modified transition or retrospective approach. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the preferred transition approach and assessing the impact of the ASU on our disclosures and financial statements, including the timing of adoption.

In July 2025, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2025-05, *Measurement of Credit Losses for Accounts Receivable and Contract Assets*, ("ASU 2025-05") which provides a practical expedient to measure credit losses on accounts receivable and contract assets. ASU 2025-05 is effective for annual periods beginning after December 15, 2025, and interim periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of the adoption and the impact of ASU 2025-05 on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-03, *Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which requires disclosure in the notes to the financial statements of specified information about certain costs and expenses. In January 2025, the FASB issued ASU 2025-01, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date," which clarifies that all public business entities should initially adopt the disclosure requirements in the final annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The new guidance is effective for fiscal years beginning after December 15, 2026, which is our annual period beginning January 1, 2027, and interim reporting periods beginning after December 15, 2027, which will be our interim period beginning January 1, 2028. Early adoption of ASU 2024-03 is permitted. We are evaluating the impact of ASU 2025-01 in conjunction with ASU 2024-03.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **REVENUE** 

**Disaggregation of Revenue**

The following tables present the Company's revenue disaggregated by contract type and revenue recognition method:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Government subcontracts | $15522738 | $16986106 | $39115821 | $48951748 |
| Prime government contracts | 2560673 | 1673483 | 6689643 | 7056711 |
| Commercial contracts | 1185691 | 760290 | 4043354 | 3302897 |
|  | $19269102 | $19419879 | $49848818 | $59311356 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue recognized using over time revenue recognition model | $19087180 | $19092000 | $49412696 | $58558552 |
| Revenue recognized using point in time revenue recognition model | 181922 | 327879 | 436122 | 752804 |
|  | $19269102 | $19419879 | $49848818 | $59311356 |

---

***Favorable/(Unfavorable) Adjustments to Gross Profit***

We review our Estimates at Completion ("EAC") at least quarterly. Due to the nature of the work required to be performed on many of the Company's performance obligations, the estimation of total revenue and cost at completion is complex, subject to many inputs, and requires significant judgment by management on a contract-by-contract basis. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities, and the related changes in estimates of revenues and costs. The risks and opportunities relate to management's judgment about the ability and cost to achieve the schedule, consideration of customer-directed delays or reductions in scheduled deliveries, technical requirements, customer activity levels, and related variable consideration. Management must make assumptions and estimates regarding contract revenue and costs, including estimates of labor productivity and availability, the complexity and scope of the work to be performed, the availability and cost of materials including any impact from changing costs or inflation, the length of time to complete the performance obligation, the availability and timing of funding from our customer, and overhead cost rates, among others.

Changes in estimates of net sales, cost of sales, and the related impact to operating profit on contracts recognized over time are recognized on a cumulative catch-up basis, which recognizes the cumulative effect of the profit changes on current and prior periods based on a performance obligation's percentage-of-completion in the current period. A significant change in one or more of these estimates could affect the profitability of one or more of our performance obligations. Our EAC adjustments also include the establishment of, and changes to, loss provisions for our contracts accounted for on a percentage-of-completion basis.

Net EAC adjustments had the following impact on our gross profit during the three and nine months ended September 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp; Net Adjustment | $(1014387) | $(865493) | $(8109975) | $(2223671) |

---

The net adjustment of $1.0 million for the three months ended September 30, 2025 is driven primarily by an unfavorable adjustment associated with the F-16 Rudder Island program, and increased labor and material costs on the NGJ Mid-Band Pod, and Embraer Phenom-300 Engine Inlets Assembly programs.

The net adjustment of $8.1 million for the nine months ended September 30, 2025 is driven primarily by an unfavorable adjustment associated with the termination of the Boeing A-10 program and increased labor and material costs on the NGJ Mid-Band Pod, T-38 Classic Structural Modification Kits and Embraer Phenom-300 Engine Inlets Assembly programs.

**Transaction Price Allocated to Remaining Performance Obligations**

As of September 30, 2025, the aggregate amount of transaction price allocated to the remaining performance obligations was approximately $100.1 million. This represents the amount of revenue the Company expects to recognize in the future on contracts with unsatisfied or partially satisfied performance obligations as of September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **CONTRACT ASSETS AND LIABILITIES** 

Contract assets represent revenue recognized on contracts in excess of amounts invoiced to the customers and the Company's right to consideration is conditional on something other than the passage of time. Amounts may not exceed their net realizable value. Under the typical payment terms of our government as well as military contractor contracts, the customer retains a portion of the contract price until completion of the contract, as a measure of protection for the customer. Our government and military contract or contracts therefore typically result in revenue recognized in excess of billings, which we present as contract assets. Contract assets are classified as current assets. The Company's contract liabilities represent customer payments received or due from the customer in excess of revenue recognized. Contract liabilities are classified as current liabilities.

Schedule of contract assets and liabilities

---

| | | | |
|:---|:---|:---|:---|
|  | **September 30,** <br>**2025**  | **December 31,** <br>**2024** | **December 31,**<br>**2023**  |
| &nbsp;&nbsp;&nbsp;Contract assets | $33695994 | $32832290 | $35312068 |
| &nbsp;&nbsp;&nbsp;Contract liabilities | 1992910 | 2430663 | 5937629 |

---

Revenue recognized for the nine months ended September 30, 2025 and 2024 that was included in the contract liabilities balance as of January 1, 2025 and 2024, was approximately $1.6 million and $5.0 million, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **INVENTORY** 

The components of inventory consisted of the following:

---

| | | |
|:---|:---|:---|
|  | **September 30,** <br> **2025**  | **December 31,** <br>**2024**  |
| Raw materials | $275888 | $414806 |
| Work in progress | 7166 | 60719 |
| Finished goods | 310551 | 442763 |
| &nbsp;&nbsp;&nbsp;Inventory | $593605 | $918288 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **STOCK-BASED COMPENSATION** 

In 2009, the Company adopted the Performance Equity Plan 2009 (the "2009 Plan"). The 2009 Plan reserved 500,000 common shares for issuance. The 2009 Plan provides for the issuance of either incentive stock options or nonqualified stock options to employees, consultants or others who provide services to the Company. The Company has 2,364 shares available for grant under the 2009 Plan as of September 30, 2025.

In 2016, the Company adopted the 2016 Long Term Incentive Plan (the "2016 Plan"). The 2016 Plan reserved 600,000 common shares for issuance, provided that no more than 200,000 common shares be granted as incentive stock options. Awards may be made or granted to employees, officers, directors and consultants in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. Any shares of common stock granted in connection with awards other than stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one and one-half shares of common stock for every one share of common stock granted in connection with such award. Any shares of common stock granted in connection with stock options and stock appreciation rights are counted against the number of shares reserved for issuance under the 2016 Plan as one share for every one share of common stock issuable upon the exercise of such stock option or stock appreciation right awarded. In the fourth quarter of 2020, the Company added 800,000 shares to the 2016 Plan, which increased the number of shares reserved for issuance under the 2016 Plan to 1,400,000 shares. In the second quarter of 2023, the Company added an additional 800,000 shares to the 2016 Plan, which increased the number of shares for reserved for issuance under the 2016 Plan to 2,200,000 shares. The Company has 292,985 shares available for grant under the 2016 Plan as of September 30, 2025.

On June 24, 2025, the shareholders of the Company approved the 2025 Long-Term Incentive Plan (the "2025 Plan") at the Company's 2025 annual meeting of shareholders. The 2025 Plan had previously been approved by the Company's Board of Directors (the "Board") on April 28, 2025, upon the recommendation of the Company's Compensation and Human Resources Committee, subject to shareholder approval. The 2025 Plan is intended to advance the Company's interests by providing equity-based incentives to attract, retain, and motivate employees, officers, directors, and consultants. The plan authorizes the issuance of up to 800,000 shares of the Company's common stock and allows for a variety of award types, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, and other stock-based awards. The 2025 Plan is administered by the Company's Compensation and Human Resources Committee, which has broad authority to determine the terms of individual awards, including eligibility, size, vesting conditions, performance criteria, and other terms. Awards may generally not be transferred and are subject to forfeiture under certain conditions. As of September 30, 2025, the Company had not issued any shares from the 2025 Plan.

Stock-based compensation expense for restricted stock in the consolidated statements of operations is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Cost of sales | $— | $14430 | $— | $3675 |
| Selling, general and administrative | 102206 | 58283 | 591018 | 526096 |
| Total stock-based compensation expense | $102206 | $72713 | $591018 | $529771 |

---

The Company grants restricted stock units ("RSUs") to directors as partial compensation. These RSUs vest quarterly on a straight-line basis over a one-year period and will fully vest on October 1, 2025.

The following table summarizes activity related to outstanding RSUs for the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **RSUs** | **Weighted** <br> **Average** <br> **Grant Date**<br>**Fair Value of** <br> **RSUs** |
| Non-vested – January 1, 2025 |  | $— |
| Granted | 122224 | $4.29 |
| Vested | (91665) | $4.29 |
| Forfeited | (3704) | $4.29 |
| Non-vested – September 30, 2025 | 26855 | $4.29 |

---

The Company grants shares of common stock ("Restricted Stock Awards" or "RSAs") to select employees. These shares have various vesting dates, ranging from vesting on the grant date to as late as four years from the date of grant. In the event that the employee's employment is voluntarily terminated prior to certain vesting dates, portions of the shares may be forfeited. At September 30, 2025, the weighted average remaining amortization period was 1.9 years.

The following table summarizes activity related to outstanding Restricted Stock Awards for the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **Restricted** <br>**Stock Awards**  | **Weighted** <br> **Average** <br> **Grant Date**<br>**Fair Value of** <br> **Restricted**<br> **Stock Awards**  |
| Non-vested – January 1, 2025 | 152875 | $2.86 |
| Granted |  | $— |
| Vested | (44075) | $2.98 |
| Forfeited | (20000) | $2.65 |
| Non-vested – September 30, 2025 | 88800 | $2.85 |

---

The Company grants shares of common stock ("Performance Restricted Stock Awards" or "PRSAs") to select officers as part of our long-term incentive program that will result in that number of PRSAs being paid out if the target performance metric is achieved. The award vesting is based on specific performance metrics related to accounts payable delinquency, debt, and net income during the performance period. The PRSAs vest at 0% or 100% and all three metrics must be met to vest at 100%. The PRSAs granted under this program will vest on the fourth anniversary of the grant date, subject to the aforementioned performance criteria. At September 30, 2025, weighted average remaining amortization period was 0.5 years.

The following table summarizes activity related to outstanding PRSAs for the nine months ended September 30, 2025:

---

| | | |
|:---|:---|:---|
|  | **PRSAs** | **Weighted** <br> **Average Grant** <br> **Date** <br>**Fair Value of** <br>**PRSAs**  |
| Non-vested – January 1, 2025 | 44076 | $2.98 |
| Granted | 42572 | $2.94 |
| Vested |  | $— |
| Forfeited | (44076) | $2.98 |
| Non-vested – September 30, 2025 | 42572 | $2.94 |

---

The fair value of all RSUs, PRSAs and RSAs is based on the closing price of our common stock on the grant date. All RSUs, PRSAs, and Restricted Stock Awards vest and settle in common stock (on a one-for-one basis).

As of September 30, 2025, unamortized stock-based compensation costs related to restricted share arrangements was $114,831.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**6.** **NET INCOME (LOSS) PER SHARE** 

Basic loss per common share is computed using the weighted average number of common shares outstanding. Diluted income per common share is adjusted for the incremental shares attributed to unvested RSUs and RSAs. Incremental shares of 54,706 were used in the calculation of diluted income per common share for the three months ended September 30, 2025. Diluted loss per common share for the nine months ended September 30, 2025 is computed using the weighted-average number of common shares outstanding adjusted for the securities attributed to unvested RSUs and unvested RSAs. Securities that could potentially dilute basic earnings per share in the future, but that were excluded from the computation of diluted earnings per share because they were antidilutive for the nine months ended September 30, 2025 include 26,855 RSU and 88,800 RSA. Incremental shares of 70,105 and 90,463 were used in the calculation of diluted income per common share for the three and nine months ended September 30, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**7.** **LINE OF CREDIT AND LONG-TERM DEBT** 

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the "Credit Agreement" or the "BankUnited Facility"). The BankUnited Facility originally provided for a revolving credit loan commitment of $30 million (the "Revolving Credit Loans") and a $10 million term loan ("Term Loan"). The Term Loan has been repaid. The Revolving Credit Loans bear interest at a rate based upon a pricing grid, as defined in the Credit Agreement.

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the "Thirteenth Amendment"). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company's Revolving Credit Loans to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the "Fourteenth Amendment"). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company's Revolving Credit Loans to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment (the "Additional Payment Obligation").

As of March 31, 2025, the Company was not in compliance with the Credit Agreement's minimum debt service coverage ratio, minimum fiscal quarter net income after taxes, and minimum quarterly adjusted EBITDA financial covenants and the Company obtained a written waiver from the Lenders waiving the specified covenant non-compliance for the fiscal quarter ended March 31, 2025.

As of June 30, 2025, the Company was not in compliance with all the Credit Agreement's financial covenants. In addition, the Company did not satisfy the July 1, 2025 mandatory repayment requirement under the Credit Agreement (the "July 2025 Payment Obligation"). On August 14, 2025, the Company obtained a written waiver from the Lenders pursuant to which the Lenders (i) waived the financial covenant non-compliance for the fiscal quarter ended June 30, 2025 and (ii) temporarily waived non-compliance with the July 2025 Payment Obligation until September 30, 2025.

On August 19, 2025, the Company executed a Fifteenth Amendment to the Credit Agreement (the "Fifteenth Amendment"). The amendment revised certain financial covenants to reflect specified adjustments for the quarters ended March 31, 2025 and June 30, 2025. These covenant-based adjustments were designed to offset the effect of the termination of the Company's Boeing A-10 Program on covenant compliance.

As of September 30, 2025, the Company was not in compliance with the aggregate principal amount of all Revolving Credit Loans and the Company obtained a Waiver and Sixteenth Amendment to the Credit Agreement (the "Sixteenth Amendment"). The Sixteenth Amendment reset the aggregate maximum principal amount of all Revolving Credit Loans to $15,890,000 from July 1, 2025 through March 31, 2026, $15,140,000 from April 1, 2026 through June 30, 2026, $14,390,000 from July 1, 2026 through September 30, 2026, and $13,640,000 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period, and waived the Company's failure to make the July 2025 Payment Obligation on September 30, 2025. The Sixteenth Amendment also extended the maturity date of the Revolving Credit Loans to November 30, 2026, and waived the Additional Payment Obligation.

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million (collectively, the "Financial Covenants"). In accordance with ASC 470, the Company has determined that it is reasonably possible it will meet its covenants within the next 12 months.

Although waivers and Credit Agreement amendments cured the events of defaults described above, the Company's failure to comply with the Financial Covenants in future periods or make mandatory repayments could result in additional events of default, and unless further waivers or amendments are obtained, of which there is no assurance, future non-compliance could permit the Lenders to accelerate the Company's outstanding obligations under the Credit Agreement and exercise other remedies available under the loan documents.

The BankUnited Facility is secured by all the Company's assets and the Revolving Credit Loans bore interest at the Prime Rate + 2.0%. The Prime Rate was 7.25% as of September 30, 2025 and as such, the Company's interest rate on the Revolving Credit Loans was 9.5% as of September 30, 2025.

As of September 30, 2025 and December 31, 2024, the Company had $15,890,000 and $17,390,000 outstanding under the Revolving Credit Loans, respectively. $1,500,000 of the Revolving Credit Loans is payable by September 30, 2026 and the remaining balance of $14,390,000 of the Revolving Credit Loans matures and is payable by November 30, 2026, as amended November 13, 2025.

The Company has cumulatively paid approximately $962,000 of total debt issuance costs in connection with the BankUnited Facility, of which approximately $20,000 and $36,000 is unamortized and is included in other assets at September 30, 2025 and December 31, 2024, respectively.

Also included in short-term debt is financing leases of $5,449 and $26,483 at September 30, 2025 and December 31, 2024, respectively, included as current liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**8.** **MAJOR CUSTOMERS AND VENDORS** 

During the nine months ended September 30, 2025, our four largest customers accounted for 37%, 19%, 13% and 13% of revenue. During the nine months ended September 30, 2024, our four largest customers accounted for 35%, 24%, 12%, and 12% of revenue. During the three months ended September 30, 2025, our three largest customers accounted for 46%, 13% and 12% of revenue. During the three months ended September 30, 2024, our three largest customers accounted for 40%, 23% and 11% of revenue

At September 30, 2025, 54%, 13% and 11% of our accounts receivable were from three of our largest customers. At December 31, 2024, 21%, 18%, 16%, 12%, 12%, and 12% of accounts receivable were due from our six largest customers.

At September 30, 2025, 39%, 26%, and 19% of our contract assets were from three of our largest customers. At December 31, 2024, 27%, 20%, 16% and 15% of our contract assets were related to our four largest customers.

At September 30, 2025 12% of our accounts payable was from one of our largest vendors. At December 31, 2024, 13%, 12%, 11%, and 11% of our accounts payable was from our top 4 largest vendors.

**9.** **LEASES** 

The Company leases manufacturing and office space under an agreement classified as an operating lease. The company entered into an amendment to the lease agreement for its operating facility on April 15, 2025 that extends the term of the lease until April 30, 2031. The lease agreement does not include any renewal options. The agreement provides for an initial monthly base amount plus annual escalations through the term of the lease. In addition to the monthly base amounts in the lease agreement, the Company is required to pay real estate taxes and operating expenses during the lease terms.

The Company also leases office equipment in agreements classified as operating leases.

For the nine months ended September 30, 2025 and 2024, the Company's operating lease expense was $1,784,937 and $1,611,487, respectively. For the three months ended September 30, 2025 and 2024, the Company's operating lease expense was $594,979 and $528,127, respectively.

Future minimum lease payments under non-cancellable operating leases as of September 30, 2025 were as follows:

---

| | |
|:---|:---|
| **For the Year Ending December 31,** | |
| Remainder of 2025 | $576133 |
| 2026 | 2304533 |
| 2027 | 2336077 |
| 2028 | 2300990 |
| 2029 | 2360515 |
| Thereafter | 3249720 |
| Total undiscounted operating lease payments | 13127968 |
| Less imputed interest | (3002734) |
| Present value of operating lease payments | $10125234 |

---

The following table sets forth the right-of-use assets and operating lease liabilities as of:

---

| | | |
|:---|:---|:---|
|  | **September 30,<br> 2025** | **December 31, <br> 2024** |
| **Assets** |  |  |
| Right-of-use assets, net | $9871784 | $2856200 |
| **Liabilities** |  |  |
| Current operating lease liabilities | $1400596 | $2162154 |
| Long-term operating lease liabilities | 8724638 | 938418 |
| &nbsp;&nbsp;&nbsp;Total lease liabilities | $10125234 | $3100572 |

---

The Company's weighted average remaining lease term for its operating leases is 5.5 years as of September 30, 2025. The Company's weighted average discount rate for its operating leases is 9.5% as of September 30, 2025.

**10.**&nbsp;&nbsp;&nbsp;&nbsp; **INCOME TAXES**

On July 4, 2025, H.R.1, commonly referred to as the One Big Beautiful Bill Act ("OBBBA") was enacted. OBBBA includes a broad range of tax reform provisions affecting businesses. The Company does not expect this legislation to have a significant impact on its financial statements.

The (benefit)/provision for income tax for the nine months ended September 30, 2025 and 2024 was $(1,043,373) and $535,634, respectively. The provision for income tax for the three months ended September 30, 2025, and September 30, 2024 was $253,345 and $154,590, respectively.

The effective income tax rate for the nine months ended September 30, 2025 is 40.5%. The difference between the effective income tax rate for the nine months ended September 30, 2025 and the statutory income tax rate of 21% is due primarily to the estimated R&D credit, state income taxes and permanent tax differences.

The effective income tax rate for the three months ended September 30, 2025 is 18.5%. The difference between the effective income tax rate for the three months ended September 30, 2025 and the statutory income tax rate of 21% is due primarily to the estimated R&D credit, state income taxes and permanent tax differences.

**11.** **COMMITMENTS AND CONTINGENCIES** 

The Company may be involved in various claims, suits, assessments, investigations, and legal proceedings that arise from time to time in the ordinary course of its business. The Company accrues a liability when it is both probable a liability has been incurred and the amount of the loss can be reasonably estimated. The Company reviews these accruals at least quarterly and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel, and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations, or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period such determination is made. For some matters, the amount of liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made.

**12.** **SEGMENT REPORTING** 

We manage our business activities on a consolidated basis and operate as a single operating segment. We primarily derive our revenue in the United States by supplying aircraft parts, complex aerostructure assemblies, aerosystems, maintenance repair and overhaul ("MRO") and kitting contracts for fixed wing aircraft and helicopters in both the commercial and defense markets. The accounting policies are the same as those described in Note 1 – Principal Business Activity and Summary of Significant Accounting Policies of the form 10-K.

Our CODM is our Chief Executive Officer, Dorith Hakim. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions including the allocation of resources and assessing financial performance.

As the Company has only one operating segment and is managed on a consolidated basis, the measure of profit or loss is consolidated net income or loss, which include all significant expenses and assets as presented in the consolidated financial statements which is consistent with the information provided to the CODM. Refer to the Condensed Consolidated Balance Sheet as of September 30, 2025 and December 31, 2024 and the Condensed Consolidated Statements of Operations for the financial information with respect to the Company's single operating segment for the three and nine months ended September 30, 2025 and 2024.

**13.** **RISK AND UNCERTAINTIES** 

***Economic Environment***

New or increased economic and trade sanctions, including tariffs, may create economic and political uncertainties and could potentially impact the cost of our raw materials and subassemblies having an adverse effect on our business, operations and profitability. Although our supply chain predominantly consists of US based suppliers, and our material costs are established on issued purchase orders, future procurements may be impacted by economic and political uncertainties including tariffs, and may directly affect the Company's profitability on previously negotiated firm fixed price contracts.

On October 1, 2025, the federal government entered a shutdown, after Congress failed to reach an agreement on a short-term spending deal or full-year appropriation. The defense industry, including our company, could be impacted if the shutdown becomes prolonged, stemming from slow downs in incremental funding on existing contracts or delays in payments on government contract invoices. Since government employees are furloughed, many critical operations will cease, including purchase order acceptance and new contract awards.

***Boeing A-10 Program Contract Termination***

On May 7, 2025, the Company submitted to The Boeing Company a Request for Equitable Pricing Adjustment on the Boeing A-10 program addressing higher manufacturing costs on its 2019 firm fixed price contract. Subsequently, on July 14, 2025, the Company received a Termination Notice from The Boeing Company with respect to the Boeing A-10 program directing the Company to scrap and return materials and tooling to the Air Force prior to August 15, 2025 when funding would no longer be available. The company continues to have correspondence with the Boeing Company over the termination of the Boeing A-10 program.

In light of these events, and in conjunction with the Air Force's decision to accelerate the retirement of the Boeing A-10 fleet, the Company evaluated the situation and recognized an adjustment to address the risk during the quarter ended June 30, 2025. The Company will continue to evaluate the situation and will recognize further adjustments if required, in the period in which a reasonable estimate can be determined.

**14.** **SUBSEQUENT EVENTS** 

***Credit Agreement Waiver; Sixteenth Amendment to Credit Agreement***

On November 13, 2025, the Company entered into a Sixteenth Amendment to its Credit Agreement. The amendment extended the maturity of the revolving credit facility to November 30, 2026, adjusted borrowing limits for future periods, waived a failure to pay principal, and eliminated a prior contingent payment requirement. See Note 7 for additional information concerning the amendment and the Credit Facility.

**Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following discussion should be read in conjunction with the Company's consolidated financial statements and notes thereto contained in this report.

**Forward Looking Statements**

When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the "SEC"), the words or phrases "will likely result," "management expects" or "we expect," "will continue," "is anticipated," "estimated" or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2024 (the "Form 10-K"). We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

**Business Operations**

CPI Aero is a prime contractor to the U.S. Department of Defense as well as a Tier 1 subcontractor to some of the largest aerospace and defense contractors in the world. CPI Aero provides engineering, program management, supply chain management, assembly operations and MRO services to this global network of customers. CPI Aero is recognized as a leader within the international aerospace market in such areas as aircraft structural assemblies, military advanced tactical pod structures, engine air inlets, and complex welded products. CPI Aero's customer base enjoys a unique combination of large-company capabilities, matched with small-company value, responsiveness, and personal customer service.

**Recent Developments**

***Credit Agreement Waiver***

On November 13, 2025, CPI Aerostructures, Inc. entered into a Sixteenth Amendment to its Credit Agreement with BankUnited, N.A. and the lenders party thereto. The amendment extended the maturity of the revolving credit facility to November 30, 2026, adjusted borrowing limits for future periods, waived a failure to pay principal, and eliminated a prior contingent payment requirement. For additional information, see "Liquidity and Capital Resources — Bank Credit Facilities" below.

***Appointment of Interim Chief Financial Officer***

Effective July 22, 2025, Pamela Levesque, a Company director, was appointed to the positions of Interim Chief Financial Officer and Secretary. Ms. Levesque will also serve as Interim Chief Financial Officer and Secretary of each of the Company's wholly owned subsidiaries, Welding Metallurgy, Inc. and Compac Development Corporation. Please refer to our Form 8-K filed on July 28, 2025 for additional information.

**Backlog**

We produce complex custom structural assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 ("ASC 606"). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

Our total backlog as of September 30, 2025 and December 31, 2024 is shown below.

---

| | | |
|:---|:---|:---|
| **Backlog<br> (Total)** | **September 30, <br> 2025** | **December 31,<br> 2024** |
| Funded | $100051000 | $85039000 |
| Unfunded | 408912000 | 425232000 |
| Total | $508963000 | $510271000 |

---

Approximately 96% of the total amount of our backlog at September 30, 2025 was attributable to government and military contractor contracts. Our backlog attributable to government contracts at September 30, 2025 and December 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
| **Backlog <br> (Government)** | **September 30, <br> 2025** | **December 31,<br> 2024** |
| Funded | $97091000 | $82262000 |
| Unfunded | 390875000 | 404256000 |
| Total | $487966000 | $486518000 |

---

Our backlog attributable to commercial contracts at September 30, 2025 and December 31, 2024 was as follows:

---

| | | |
|:---|:---|:---|
| **Backlog<br> (Commercial)** | **September 30, <br> 2025** | **December 31,<br> 2024** |
| Funded | $2960000 | $2777000 |
| Unfunded | 18037000 | 20976000 |
| Total | $20997000 | $23753000 |

---

The total backlog at September 30, 2025 is primarily comprised of long-term programs with Raytheon (NGJ Mid-Band Pods and Advanced Tactical Pods), L3Harris (NGJ Low-Band Pods), Lockheed Martin (F-16 RI/DCC's), Raytheon (B-52 Radar Racks), Sikorsky (MH-60 Seahawk Stabilator MRO).

The funded backlog at September 30, 2025 is primarily from purchase orders under long-term contracts with Raytheon (NGJ Mid-Band Pods and Advanced Tactical Pods), USAF (T-38 Classic Structural Modification Kits) and Lockheed Martin (F-16 RI/DCC's).

**Critical Accounting Estimates**

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See *Management's Discussion and Analysis of Financial Condition and Results of Operations* in the Form 10-K, for a discussion of our critical accounting estimates. There have been no significant changes to the application of our critical accounting estimates during the nine months ended September 30, 2025.

**Results of Operations**

***Revenue***

Total Revenue for the three months ended September 30, 2025 was $19,269,102 compared to $19,419,879 for the same period last year, a decrease of $150,777 or 0.8%, driven primarily by the termination of the Boeing A-10 Main Landing Gear Pods program offset by timing of material receipts to our NGJ Mid-Band Pods Programs.

Total Revenue for the nine months ended September 30, 2025 was $49,848,818 compared to $59,311,356 for the same period last year, a decrease of $9,462,538 or 16%, driven primarily by the unfavorable adjustment associated with the termination of the Boeing A-10 Main Landing Gear Pods program, timing of material receipts on our MS-110/TACSAR pod program and completion of the F-35 program, offset by higher production volume in our NGJ Mid-Band Pods and MH-60 Seahawk Stabilator MRO programs.

Revenue from military subcontracts was $15,522,738 for the three months ended September 30, 2025 compared to $16,986,106 for the three months ended September 30, 2024, a decrease of $1,463,368 or 8.6%, driven primarily associated with the termination of the Boeing A-10 Main Landing Gear Pods program and lower revenue on the Sikorsky CH-53K Welded Tubes program offset by timing of material receipts on our NGJ Mid-Band Pods Programs.

Revenue from military subcontracts was $39,115,821 for the nine months ended September 30, 2025 compared to $48,951,748 for the nine months ended September 30, 2024, a decrease of $9,835,927 or 20.1%, driven primarily by the unfavorable adjustment associated with the termination of the Boeing A-10 Main Landing Gear Pods program, timing of material receipts on our MS-110/TACSAR pod program and completion of the F-35 program, offset by higher production volume in our NGJ Mid-Band Pods and MH-60 Seahawk Stabilator MRO programs.

Revenue from government military contracts was $2,560,673 for the three months ended September 30, 2025 compared to $1,673,483 for the three months ended September 30, 2024, an increase of $887,190 or 53.0%, driven primarily by timing of material receipts in our USAF T-38 Pacer Classic Structural Modification Kits program.

Revenue from government military contracts was $6,689,643 for the nine months ended September 30, 2025 compared to $7,056,711 for the nine months ended September 30, 2024, a decrease of $367,068 or 5.2%, driven primarily by timing of material receipts in our USAF T-38 Pacer Classic Structural Modification Kits program.

Revenue from commercial subcontracts was $1,185,691 for the three months ended September 30, 2025 compared to $760,290 for the three months ended September 30, 2024, an increase of $425,401 or 56.0%, driven primarily by the commencement in our Embraer Phenom-100 Engine Inlet Assemblies programs.

Revenue from commercial subcontracts was $4,043,354 for the nine months ended September 30, 2025 compared to $3,302,897 for the nine months ended September 30, 2024, an increase of $740,457 or 22.4%, primarily driven by the commencement in our Embraer Phenom-100 Engine Inlet Assemblies and Collins Compac Enclosures programs.

***Cost of Sales***

Total Cost of Sales for the three months ended September 30, 2025 and 2024 was $14,962,788 and $15,200,210, respectively, a decrease of $237,422 or 1.6%.

Total Cost of Sales for the nine months ended September 30, 2025 and 2024 was $43,229,647 and $46,422,514, respectively, a decrease of $3,192,867 or 6.9%.

The components of the cost of sales were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
|  | **September 30,<br> 2025** | **September 30,<br> 2024** | **September 30,<br> 2025** | **September 30,<br> 2024** |
| Procurement | $9605276 | $9219097 | $26760166 | $28702158 |
| Labor | 1470358 | 1861505 | 4617419 | 5460235 |
| Factory overhead | 4101453 | 4021411 | 12172384 | 12058902 |
| Other cost of sales | (214299) | 98197 | (320322) | 201219 |
| **Cost of sales** | $**14962788** | $**15200210** | $**43229647** | $**46422514** |

---

Procurement for the three months ended September 30, 2025 was $9,605,276 compared to $9,219,097 for the three months ended September 30, 2024, an increase of $386,179 or 4.2%, driven primarily by increased material receipts for our NGJ Mid-band pod and USAF T-38 Pacer Classic Structural Modification Kits programs offset by the termination of the Boeing A-10 Main Landing Gear Pods program.

Procurement for the nine months ended September 30, 2025 was $26,760,166 compared to $28,702,158 for the nine months ended September 30, 2024, a decrease of $1,941,992 or 6.8%, driven primarily by the termination of the Boeing A-10 Main Landing Gear Pods program and lower material receipts on the Collins MS-110 program, offset by increased material receipts on our NGJ POD program.

Labor costs for the three months ended September 30, 2025 were $1,470,358 compared to $1,861,505 for the three months ended September 30, 2024, a decrease of $391,147 or 21.0% primarily driven by the termination of the Boeing A-10 Main Landing Gear Pods program.

Labor costs for the nine months ended September 30, 2025 were $4,617,419 compared to $5,460,235 for the nine months ended September 30, 2024, a decrease of $842,816 or 15.4% primarily driven by the termination of the Boeing A-10 Main Landing Gear Pods program and timing of work performed on the F-16 Rudder Island program.

Factory overhead for the three months ended September 30, 2025 was $4,101,453 compared to $4,021,411 for the three months ended September 30, 2024, an increase of $80,042 or 2.0%.

Factory overhead for the nine months ended September 30, 2025 was $12,172,384 compared to $12,058,902 for the nine months ended September 30, 2024, an increase of $113,482 or 0.9%.

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other cost of sales for the three months ended September 30, 2025 was $(214,299) compared to a $98,197 for the three months ended September 30, 2024, a decrease of $312,496 or 318.2%. The decrease is primarily the benefits realized on programs nearing completion.

Other cost of sales for the nine months ended September 30, 2025 was $(320,322) compared to $201,219 for the nine months ended September 30, 2024, a decrease in cost of $521,541 or 259.2%. The decrease is primarily driven by benefits realized on programs nearing completion during the three months ended March 31, 2025 partially offset by changes in inventory loss reserve.

***Gross Profit***

Gross profit and gross profit percentage ("gross margin") for the three months ended September 30, 2025 and September 30, 2024 was $4,306,314 and 22.3% compared to $4,219,669 and 21.7% respectively, an increase of $86,645 or 2.1%, and 60 basis points for the reasons noted above.

Gross margin for the nine months ended September 30, 2025 was $6,619,171 and 13.3%, respectively, compared to $12,888,842 and 21.7%, respectively, for the nine months ended September 30, 2024, a decrease of $6,269,671 or 48.6%, and 840 basis points for the reasons noted above.

***Favorable/Unfavorable Adjustments to Gross Profit***

During the three and nine months ended September 30, 2025 and 2024, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended<br> September 30,** | **Three months ended<br> September 30,** | **Nine months ended<br> September 30,** | **Nine months ended<br> September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp; Net Adjustment | $(1014387) | $(865493) | $(8109975) | $(2223671) |

---

The net adjustment of $1.0 million for the three months ended September 30, 2025 is driven primarily by an unfavorable adjustment associated with the F-16 Rudder Island program, and increased labor and material costs on the NGJ Mid-Band Pod, and Embraer Phenom-300 Engine Inlets Assembly programs.

The net adjustment of $8.1 million for the nine months ended September 30, 2025 is driven primarily by an unfavorable adjustment associated with the termination of the Boeing A-10 program and increased labor and material costs on the NGJ Mid-Band Pod, T-38 Classic Structural Modification Kits and Embraer Phenom-300 Engine Inlets Assembly programs.

***Selling, General and Administrative Expenses***

Selling, general and administrative expenses for the three months ended September 30, 2025 were $2,551,355 compared to $2,742,036 for the three months ended September 30, 2024, a decrease of $190,681 or 7.0%. The decrease was primarily due to lower salary related costs.

Selling, general and administrative expenses for the nine months ended September 30, 2025 were $8,041,156 compared to $8,231,875 for the nine months ended September 30, 2024, a decrease of $190,719 or 2.3%. The decrease was primarily due to lower salary related costs.

***Interest expense***

Interest expense for the three months ended September 30, 2025 was $387,922, compared to $573,366 for the three months ended September 30, 2024, a decrease of $185,444 or 32.3%. The decrease was primarily the result of lower year-over-year interest rates charged on our outstanding debt under the Credit Agreement, combined with a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

Interest expense for the nine months ended September 30, 2025 was $1,163,559, compared to $1,793,472 for the nine months ended September 30, 2024, a decrease of $629,913 or 35.1%. The decrease was the result of lower year-over-year interest rates charged on our outstanding debt under the Credit Agreement, combined with a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

***Income (loss) Before Provision for Income Taxes***

Income before provision for income taxes for the three months ended September 30, 2025 was $1,367,037 compared to $904,267 for the three months ended September 30, 2024.

(Loss) income before provision for income taxes for the nine months ended September 30, 2025 was ($2,578,564) compared to $2,863,495 for the nine months ended September 30, 2024.

***(Benefit)/Provision for Income Taxes***

Provision for income taxes for the three months ended September 30, 2025 was $253,345 compared to provision for income taxes of $154,590 for the three months ended September 30, 2024, an increase of $98,755 or 63.9% is primarily related to the increase in net income.

The effective income tax rate for the three months ended September 30, 2025 and September 30, 2024 is 18.5% and 17.1%, respectively. The difference between the effective income tax rate for the three months ended September 30, 2025 and the statutory income tax rate of 21% is primarily due to the estimated R&D credit, state income taxes and permanent tax differences. The difference between the effective income tax rate for the three months ended September 30, 2024 and the statutory income tax rate of 21% is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

(Benefit)/provision for income taxes for the nine months ended September 30, 2025 was $(1,043,373) compared to a provision for income taxes of $535,634 for the nine months ended September 30, 2024, a benefit increase of $1,579,007 or 294.8% is primarily the result of the change in net income for the period.

The effective income tax rate for the nine months ended September 30, 2025 and September 30, 2024 is 40.5% and 18.7%, respectively. The difference between the effective income tax rate for the nine months ended September 30, 2025 and the statutory income tax rate of 21% is primarily due to the estimated R&D credit, state income taxes and permanent tax differences. The difference between the effective income tax rate for the nine months ended September 30, 2024 and the statutory income tax rate of 21% is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

***Net Income/(Loss) and Earnings per Share***

Net income for the three months ended September 30, 2025 was $1,113,692 or $0.09 per basic share using 12,763,486 weighted average basic shares outstanding, compared to net income of $749,677 or $0.06 per basic share using 12,647,023 weighted average basic shares outstanding, for the same period last year. Diluted income per share was $0.09 for the three months ended September 30, 2025 calculated utilizing 12,818,191 weighted average shares outstanding. Diluted income per share was $0.06 for the three months ended September 30, 2024 calculated utilizing 12,717,128 weighted average shares outstanding. The increase in net income was primarily driven by decreases in selling, general and administrative expenses and interest expense.

Net (loss) income for the nine months ended September 30, 2025 was $(1,535,191) or $(0.12) per basic share using 12,740,097 weighted average basic shares outstanding, compared to net income of $2,327,861 or $0.19 per basic share using 12,559,876 weighted average basic shares outstanding, for the same period last year. Diluted (loss) per share was $(0.12) for the nine months ended September 30, 2025 calculated utilizing 12,740,097 weighted average shares outstanding. Diluted income per share was $0.18 for the nine months ended September 30, 2024 calculated utilizing 12,650,340 weighted average shares outstanding. The decrease in net income was primarily driven by a decrease in gross profit offset by the benefit increase in income taxes.

**Liquidity and Capital Resources**

***General***

At September 30, 2025, we had working capital of $15,836,054 compared to $17,122,111 at December 31, 2024, a decrease of $1,286,057 or 7.5%. The decrease was driven primarily by a decrease in cash and accrued liabilities offset by increases in accounts payable, accounts receivable, contract assets and current portion of line of credit.

***Cash Flow***

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.

Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

At September 30, 2025, we had cash of $546,591 compared to $5,490,963 at December 31, 2024, a decrease of $4,944,372 or 90%. This decrease was primarily the result of cash flow used in operating activities and repayment of debt.

***Bank Credit Facilities***

On March 24, 2016, the Company entered into the Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the "Credit Agreement" or the "BankUnited Facility"). The BankUnited Facility originally provided for a revolving credit loan commitment of $30 million (the "Revolving Credit Loans") and a $10 million term loan ("Term Loan"). The Term Loan has been repaid. The Revolving Loan bears interest at a rate based upon a pricing grid, as defined in the Credit Agreement.

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the "Thirteenth Amendment"). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company's Revolving Credit Loans to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the "Fourteenth Amendment"). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company's Revolving Credit Loans to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment (the "Additional Payment Obligation").

As of March 31, 2025, the Company was not in compliance with the Credit Agreement's minimum debt service coverage ratio, minimum fiscal quarter net income after taxes, and minimum quarterly adjusted EBITDA financial covenants and the Company obtained a written waiver from the Lenders waiving the specified covenant non-compliance for the fiscal quarter ended March 31, 2025.

As of June 30, 2025, the Company was not in compliance with all the Credit Agreement's financial covenants. In addition, the Company did not satisfy the July 1, 2025 mandatory repayment requirement under the Credit Agreement (the "July 2025 Payment Obligation"). On August 14, 2025, the Company obtained a written waiver from the Lenders pursuant to which the Lenders (i) waived the financial covenant non-compliance for the fiscal quarter ended June 30, 2025 and (ii) temporarily waived non-compliance with the July 2025 Payment Obligation until September 30, 2025.

On August 19, 2025, the Company executed a Fifteenth Amendment to the Credit Agreement (the "Fifteenth Amendment"). The amendment revised certain financial covenants to reflect specified adjustments for the quarters ended March 31, 2025 and June 30, 2025. These covenant-based adjustments were designed to offset the effect of the termination of the Company's Boeing A-10 Program on covenant compliance.

As of September 30, 2025, the Company was not in compliance with the aggregate principal amount of all Revolving Credit Loans and the Company obtained a Waiver and Sixteenth Amendment to the Credit Agreement (the "Sixteenth Amendment"). The Sixteenth Amendment reset the aggregate maximum principal amount of all Revolving Credit Loans to $15,890,000 from July 1, 2025 through March 31, 2026, $15,140,000 from April 1, 2026 through June 30, 2026, $14,390,000 from July 1, 2026 through September 30, 2026, and $13,640,000 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period, and waived the Company's failure to make the July 2025 Payment Obligation on September 30, 2025. The Sixteenth Amendment also extended the maturity date of the Revolving Credit Loans to November 30, 2026, and waived the Additional Payment Obligation. A copy of the Waiver and Sixteenth Amendment to the Credit Agreement is filed as Exhibit 10.1 to this Quarterly Report on Form 10-Q.

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million (collectively, the "Financial Covenants"). In accordance with ASC 470, the Company has determined that it is reasonably possible it will meet its covenants within the next 12 months.

Although waivers and Credit Agreement amendments cured the events of defaults described above, the Company's failure to comply with the financial covenants in future periods or make mandatory repayments could result in additional events of default, and unless further waivers or amendments are obtained, of which there is no assurance, future non-compliance could permit the Lenders to accelerate the Company's outstanding obligations under the Credit Agreement and exercise other remedies available under the loan documents. The Company continues to monitor its financial performance and covenant compliance and may seek further waivers or amendments, if necessary.

The BankUnited Facility is secured by all the Company's assets and the Revolving Credit Loans bore interest at the Prime Rate + 2.0%. The Prime Rate was 7.25% as of September 30, 2025 and as such, the Company's interest rate on the Revolving Credit Loans was 9.5% as of September 30, 2025.

As of September 30, 2025 and December 31, 2024, the Company had $15,890,000 and $17,390,000 outstanding under the Revolving Credit Loans, respectively.

There is currently no availability for borrowings under the Revolving Credit Loans and the Company finances its operations from internally generated cash flow.

***Liquidity***

We believe that our existing resources as of September 30, 2025 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.

***Contractual Obligations***

For information concerning our contractual obligations, see *Contractual Obligations* under Item 7 of Management's Discussion and Analysis of Financial Condition and Results of Operations of the Form 10-K.

***Inflation***

Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, supply chain, labor markets and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company's long-term contracts with its customers and suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.

**Item 3 – Quantitative and Qualitative Disclosures About Market Risk**

Not applicable.

**Item 4 – Controls and Procedures**

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

● provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

● provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

***Disclosure Controls and Procedures***

Under the supervision and with the participation of our Chief Executive Officer and Interim Chief Financial Officer, management evaluated the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2025. Based on that evaluation, management concluded that our disclosure controls and procedures were not effective as of that date due to the material weakness described below.

During the second quarter, a Material Weakness was identified concerning the application of ASC-470 – *Debt,* more specifically as it relates to 470-10-45-11, that if a company is in violation of a debt covenant and it is probable that the borrower will not be able to comply with the covenant at measurement dates within the next twelve months, this debt shall be classified as short term. Due to the financial impact of the Boeing A-10 program, the Company was not able to meet the financial covenants for the second quarter and therefore obtained a waiver to remediate the non-compliance. As this waiver did not cover the twelve months from the date of the Company's financial statements the Company had a potential misclassification of short and long term debt.

On August 19, 2025, the Company executed the Fifteenth Amendment, which revised the definition of EBITDA for covenant-calculation purposes by permitting add-backs for the six months ended June 30, 2025 due to the Boeing A-10 program adjustments. The Fifteenth Amendment also has customary terms and conditions, including representations, reaffirmations of prior obligations, and related provisions.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

The Company has begun to develop new controls designed to remediate the aforementioned material weakness pertaining to the application of ASC-470 – *Debt* which the Company implemented during the quarter ended September 30, 2025.

**Changes in Internal Control Over Financial Reporting**

During the quarter ended September 30, 2025, the Company implemented a compliance checklist based on ASC 470-10 which provides guidance on the classification determination for obligations of callable debt for use by CPI's finance management in reviewing the quarterly and annual covenant requirements.

**Part II - Other Information**

**Item 1 – Legal Proceedings**

None.

**Item 1A – Risk Factors**

"Part I Item 1A - Risk Factors" of our Comprehensive Form 10-K for the year ended December 31, 2024, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors described in such report except as follows.

**Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds**

None.

**Item 3 – Defaults Upon Senior Securities**

None.

**Item 4 – Mine Safety Disclosures**

Not applicable.

**Item 5 – Other Information**

***Credit Agreement Waiver and Amendment***

On November 13, 2025, the Company entered into the Sixteenth Amendment. The Sixteenth Amendment amended the Credit Agreement by extending the maturity date of the Revolving Credit Loans to November 30, 2026, and (ii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $15,890,000 from July 1, 2025 through March 31, 2026, $15,140,000 from April 1, 2026 through June 30, 2026, $14,390,000 from July 1, 2026 through September 30, 2026, and $13,640,000 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period. The Sixteenth Amendment also waived the Company's failure make the July 2025 Payment Obligation on September 30, 2025 and waived the Additional Payment Obligation. The Sixteenth Amendment contains customary terms and conditions, including representations, reaffirmations of prior obligations, and related provisions.

The Company paid a $39,725 fee to the Lenders in connection with the Sixteenth Amendment.

The foregoing description is qualified in its entirety by reference to the Sixteenth Amendment, a copy of which is attached to this Form 10-Q as Exhibit 10.1 and incorporated herein by reference.

***Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements***

During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities and Exchange Act of 1934) adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-rule 10b5-1 trading arrangement" as each term is defined in Item 408(a) of Regulation S-K.

**Item 6 – Exhibits**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [10.1\*](ex10-1.htm) | [Waiver and Sixteenth Amendment to Amended and Restated Credit Agreement, dated as of November 13, 2025, by and among CPI Aerostructures, Inc., BankUnited, N.A., and Dime Community Bank.](ex10-1.htm) |
| [31.1\*](ex31-1.htm) | [Section 302 Certification by Chief Executive Officer and President](ex31-1.htm) |
| [31.2\*](ex31-2.htm) | [Section 302 Certification by Chief Financial Officer (Principal Accounting Officer)](ex31-2.htm) |
| [32.1\*\*](ex32-1.htm) | [Section 906 Certification by Chief Executive Officer and Chief Financial Officer](ex32-1.htm) |
| 101.INS\*\* | Inline XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH\* | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL\* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF\* | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB\* | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104\*\* | Cover Page Interactive Data File. The cover page XBRL tags are embedded within the Inline XBRL document. |

---

\* Filed herewith

\*\* Furnished herewith

Attached as Exhibit 101 to this report are the following formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statement of Operations for the three months ended September 30, 2025 and 2024, (ii) Condensed Consolidated Balance Sheet as of September 30, 2025 and December 31, 2024, (iii) Condensed Consolidated Statement of Cash Flows for the three months ended September 30, 2025 and 2024, (iv) Condensed Consolidated Statement of Changes in Equity for the three months ended September 30, 2025 and 2024 and (v) Notes to Condensed Consolidated Financial Statements.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | CPI AEROSTRUCTURES, INC. | CPI AEROSTRUCTURES, INC. |
| Dated: November 13, 2025 | By. | /s/ Dorith Hakim |
|  |  | Dorith Hakim |
|  |  | Chief Executive Officer and President <br>(Principal Executive Officer)  |
| Dated: November 13, 2025 | By. | /s/ Pamela Levesque |
|  |  | Pamela Levesque |
|  |  | Interim Chief Financial Officer <br>(Principal Financial and Accounting Officer)  |

---

## Exhibit 10.1

**[CPI AEROSTRUCTURES, INC. 10-Q](cpi-10q_093025.htm)**

**EXHIBIT 10.1**

<u>**WAIVER AND SIXTEENTH AMENDMENT**</u>

<u>**TO AMENDED AND RESTATED CREDIT AGREEMENT**</u>

**WAIVER AND SIXTEENTH AMENDMENT TO AMENDED AND RESTATED**

**CREDIT AGREEMENT** (this "**Amendment**") entered into as of November 13, 2025 by and among CPI AEROSTRUCTURES, INC. (the "**Borrower**"), BANKUNITED, N.A., a national banking association, as Sole Arranger, Agent and a Lender, DIME COMMUNITY BANK, a New York banking corporation, as a Lender, and the other financial institutions from time to time parties thereto as lenders (collectively, the "**Lenders**" and each a "**Lender**"), and BANKUNITED, N.A., a national banking association, as administrative agent and collateral agent for the Lenders thereunder (in such capacities, the "**Administrative Agent**" and the "**Collateral Agent**," respectively and each an "**Agent**").

**WHEREAS**, the Borrower, the Agent and each Lender are parties to that Amended and Restated Credit Agreement dated as of March 24, 2016, as amended by that First Amendment and Waiver to Amended and Restated Credit Agreement dated as of May 9, 2016, as further amended by that Second Amendment to Amended and Restated Credit Agreement dated as of July 13, 2017, as further amended by that Third Amendment and Waiver to Amended and Restated Credit Agreement dated as of August 15, 2018, as further amended by that Fourth Amendment dated as of December 20, 2018, as further amended by that Fifth Amendment to Amended and Restated Credit Agreement dated as of June 25, 2019, as further amended by that Sixth Amendment and Waiver to Amended and Restated Credit Agreement dated as of August 24, 2020, as further amended by that Consent, Waiver and Seventh Amendment to Amended and Restated Credit Agreement dated as of May 11, 2021, as further amended by that Waiver and Eighth Amendment to Amended and Restated Credit Agreement dated as of October 28, 2021, as further amended by that Consent, Waiver and Ninth Amendment to Amended and Restated Credit Agreement dated as of April 12, 2022, as further amended by that Consent, Waiver and Tenth Amendment to Amended and Restated Credit Agreement dated as of August 17, 2022, as further amended by that Eleventh Amendment to Amended and Restated Credit Agreement dated as of November 9, 2022, as further amended by that Twelfth Amendment to Amended and Restated Credit Agreement dated as of March 23, 2023; as further amended by that Thirteenth Amendment to Amended and Restated Credit Agreement dated as of February 20, 2024, as further amended by that Fourteenth Amendment to Amended and Restated Credit Agreement dated as of November 18, 2024 (the "**Fourteenth Amendment**") and as further amended by that Fifteenth Amendment to Amended and Restated Credit Agreement dated as of August 19, 2025 (collectively, the "**Agreement**");

**WHEREAS**, (i) Section 2.3 of the Agreement provides that the Borrower shall repay the Revolving Credit Loans on each of April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025, April

1, 2025, July 1, 2025, October 1, 2025, January 1, 2026, April 1, 2026 and July 1, 2026 in an amount equal to the difference, if greater than zero, of the aggregate principal amount of all outstanding Revolving Credit Loans at such time minus the amount of the Aggregate Revolving Credit Maximum Amount at such time (the "**Payment Obligation**") and (ii) under a letter agreement dated August 14, 2025 among the Borrower, the Agent and the Lenders, the Lenders temporarily waived the payment specified under the foregoing clause (i) that would have been payable on July 1, 2025;

**WHEREAS**, on October 1, 2025, the Aggregate Revolving Credit Maximum Amount exceeded the then-outstanding aggregate principal amount of Revolving Credit Loans, and the Borrower failed to satisfy the Payment Obligation, which failure constitutes an Event of Default under Section 8.1(a) of the Agreement (the "**Specified Event of Default**");

**WHEREAS,** Section 11 of the Fourteenth Amendment provides for an additional payment

obligation of the Borrower under certain circumstances (the "**Additional Payment Obligation**");

**WHEREAS**, the Borrower has requested that the Agent and each Lender (i) amend certain provisions of the Agreement and (ii) waive the Specified Event of Default and the Additional Payment Obligation; and

**WHEREAS**, the Agent and each Lender are willing to accede to such requests, subject to the terms and conditions hereinafter set forth.

**NOW, THEREFORE**, in consideration of the premises and the agreements hereinafter set forth and for other good and valuable consideration, the parties hereto hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. All capitalized terms used herein, unless otherwise defined herein, have the same meanings provided therefor in the Agreement. This Amendment constitutes a Loan Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Subject to the terms and conditions hereof, the Agreement is hereby amended as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Section 1.1 of the Agreement (Defined Terms) is amended by deleting the following definitions "**Aggregate Revolving Credit Maximum Amount**" and "**Revolving Credit Termination Date**," and substituting the following therefor:

"**Aggregate Revolving Credit Maximum Amount**": shall mean the principal amount of up to (a) $19,800,000 from January 1, 2024 through March 31, 2024, (b) $19,080,000 from April 1, 2024 through June 30, 2024, (c) $18,360,000 from July 1, 2024 through September 30, 2024, (d) $17,640,000 from October 1, 2024 through December 31, 2024, (e) $16,890,000 from January 1, 2025 through March 31, 2025, (f) $15,890,000 from April 1, 2025 through March 31, 2026, (g) $15,140,000 from April 1, 2026 through June 30, 2026, (h) $14,390,000 from July 1, 2026 through September 30, 2026, and (i) $13,640,000 thereafter.

"**Revolving Credit Termination Date**": November 30, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Section 2.3 of the Agreement (Repayment of Revolving Credit Loans) is amended by deleting the last sentence thereof and substituting the following therefor:

"Without limitation of the foregoing, the Borrower shall repay the Revolving Credit Loans on each of April 1, 2024, July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, April 1, 2026, July 1, 2026 and October 1, 2026 in an amount equal to the difference, if greater than zero, of the aggregate principal amount of all outstanding Revolving Credit Loans at such time minus the amount of the Aggregate Revolving Credit Maximum Amount at such time."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Schedule 4.18</u> of the Agreement is hereby amended by deleting the same and substituting the attached Schedule 4.18 therefor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Schedule 7.3</u> of the Agreement is hereby amended by deleting the same and substituting the attached Schedule 7.3 therefor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Subject to the terms and conditions hereof, the Agent and each Lender hereby
waive

(i) the Specified Event of Default and (ii) the Additional Payment Obligation. For the avoidance of doubt, as of the Effective Date (as defined below), Section 11 of the Fourteenth Amendment shall have no further force or effect and no amount shall be due or payable in respect of the Additional Payment Obligation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Each Lender and the Borrower agree that as of the date hereof, the aggregate outstanding principal amount of the Revolving Credit Loans as evidenced by Revolving Credit Notes is $15,890,000.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Borrower hereby represents and warrants to each Lender that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Each and every of the representations and warranties set forth in the Agreement is true as of the date hereof and with the same effect as though made on the date hereof and is hereby incorporated herein in full by reference as if fully restated herein in its entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No Default or Event of Default and no event or condition which, with the giving of notice or lapse of time or both, would constitute a Default or Event of Default, now exists or would exist after giving effect hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) There are no defenses or offsets to the Borrower's obligations under the Agreement, the Notes or the other Loan Documents or any of the other agreements in favor of the Lenders referred to in the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The WHEREAS clauses set forth hereinabove are true and correct.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. It is expressly understood and agreed that all collateral security for the Loans and other extensions of credit set forth in the Agreement prior to the amendment provided for herein is and shall continue to be collateral security for the Loans, obligations and other extensions of credit provided in the Agreement (as herein amended) and the other Loan Documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The amendments and waivers set forth herein are limited precisely as written, based on the facts specified, and shall not be deemed to (a) be a consent with respect to or a waiver of any other term or condition of the Agreement, the other Loan Documents or any of the documents referred to therein, or (b) prejudice any right or rights which either Lender may now have or may have in the future under or in connection with the Agreement, the other Loan Documents or any documents referred to therein. Whenever the Agreement is referred to in this Amendment, the other Loan Documents or any of the instruments, agreements or other documents or papers executed and delivered in connection therewith, it shall be deemed to mean the Agreement as modified by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. The Borrower agrees to pay on demand, and the Agent may charge any deposit or loan accounts of the Borrower, all expenses (including reasonable attorneys' fees) incurred by the Lenders in connection with the negotiation and preparation of this Amendment and all instruments, agreements and other documents executed or delivered in connection herewith.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. In consideration of the accommodations provided by the Agent and the Lenders under this Amendment, the Borrower and the Guarantors (by virtue of their undersigned consent), on behalf of themselves and for each of their direct and indirect Affiliates, successors, predecessors and assigns, and their present and former legal representatives, employees, agents, and attorneys, and their trustees, successors and assigns (collectively, the "**Releasors**"), hereby knowingly, voluntarily, intentionally, unconditionally and irrevocably waive, release and forever discharge (the "**Release**") the Agent and the Lenders and the Agent and the Lenders' Affiliates and subsidiaries (collectively, the "**Lender Parties**") from and against any and all rights, claims, counterclaims, demands, suits, actions or causes of action against the Agent or either Lender or the other Lender Parties, whether known or unknown, contingent or absolute, liquidated or unliquidated or otherwise, arising out of the Agent or the Lenders' or the other Lender Parties' actions or inactions in connection with the Loans prior to the execution and delivery of this Amendment prior to the execution and delivery of this Amendment, as well as any and all rights of setoff, defenses, claims, counterclaims, demands, suits, actions, and causes of action, in each case in connection with the Loans prior to the execution and delivery of this Amendment, and any other bar to the enforcement of the Agreement, the Notes or any of the other Loan Documents which shall have accrued prior to the execution and delivery of this Amendment. In any litigation arising from or related to an alleged breach of the Release, the Release may be pleaded as a defense, counterclaim or cross claim and shall be admissible into evidence without foundation testimony whatsoever. The Releasors expressly covenant and agree that the Release shall be binding in all respects upon their respective successors, assigns and transferees including, without limitation, any trustee in bankruptcy, and shall inure to the benefit of the successors and assigns of the Agent, the Lenders and the other Lender Parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. If any of the Borrower or the Guarantors shall (a) file with any bankruptcy or similar court or be the subject of any petition under any Debtor Relief Law; (b) be the subject of an order for relief under any Debtor Relief Law; (c) file or be the subject of a petition seeking any reorganization, arrangement, composition, readjustment, liquidation, dissolution, or similar relief under any present or future Debtor Relief Law; (d) seek, consent to or acquiesce in the appointment of a trustee, receiver, conservator or liquidator; or (e) be the subject of an order, judgment or decree entered by a court of competent jurisdiction approving a petition filed against any of the Borrower or the Guarantors for any reorganization, arrangement, composition, readjustment, liquidation, dissolution, or similar relief under any present or future Debtor Relief Law, then the Agent shall thereupon be entitled to relief from any automatic stay imposed by Section 362 of the United States Bankruptcy Code or from any other stay or suspension of remedies of the rights and remedies otherwise available to the Agent under the Agreement or any other Loan Documents, and each of the Borrower and the Guarantors specifically acknowledges that "cause" exists for such relief within the meaning of Section 362(d) of the United States Bankruptcy Code and agrees not to oppose any motion by the Agent for relief from the automatic stay imposed by Section 362.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. This Amendment shall become effective on such date as all of the following
conditions

shall be satisfied retroactive to the date set forth in the first paragraph hereof (the "**Effective Date**"):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Loan Documents</u>. The Administrative Agent shall have received counterparts of this Amendment (inclusive of all exhibits, and attachments), executed and delivered by a duly authorized officer of the Borrower and the Guarantors, with a counterpart or a conformed copy for each Lender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Secretary's Certificate of the Borrower</u>. The Administrative Agent shall have received, with a counterpart for each Lender, a certificate, dated as of the Effective Date,

executed by the Secretary or any Assistant Secretary of the Borrower certifying (i) a copy of the resolutions, in form and substance satisfactory to the Administrative Agent, of the Board of Directors of the Borrower authorizing the execution, delivery and performance of this Amendment and (ii) the incumbency and signature of the officers of the Borrower executing this Amendment and any other Loan Document, which certificate shall be in form and substance satisfactory to the Administrative Agent and shall state that the resolutions thereby certified have not been amended, modified, revoked or rescinded.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Secretary's Certificates of the Guarantors</u>. The Administrative Agent shall have received, with a counterpart for each Lender, a certificate, dated as of the Effective Date, executed by the Secretary or any Assistant Secretary of each Guarantor certifying (i) a copy of the resolutions, in form and substance satisfactory to the Administrative Agent, of the Board of Directors of such Guarantor authorizing the execution, delivery and performance of this Amendment and (ii) the incumbency and signature of the officers of such Guarantor executing this Amendment and any other Loan Document, which certificate shall be in form and substance satisfactory to the Administrative Agent and shall state that the resolutions thereby certified have not been amended, modified, revoked or rescinded.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Amendment Fee</u>. In consideration for the Lenders entering into this Amendment, the Borrower shall have paid to the Administrative Agent for the ratable benefit of the Lenders, in immediately available funds, a fee equal to $39,725.00, which fee shall be deemed fully earned and nonrefundable as of the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Fees, Costs and Expenses</u>. The Lenders shall have received all invoiced fees, costs, expenses and compensation required to be paid on the Effective Date (including reimbursement for or direct payment of the reasonable fees, disbursements and other charges of legal counsel to the Arranger, the Agent and the Lenders).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Consents, Licenses and Approvals</u>. All governmental and material third party approvals necessary in connection with the execution, delivery and performance of the Loan Documents shall have been obtained and be in full force and effect or shall continue to be in full force and effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Litigation</u>. Except as set forth on Schedule 4.6 of the Agreement, there shall be no litigation or administrative proceeding or proposed or pending regulatory changes in law or regulations applicable to the Borrower or its Subsidiaries, which, if adversely determined could reasonably be expected to have a Material Adverse Effect or a material adverse effect on the ability of the parties to consummate the execution, delivery and performance of the Loan Documents and the Borrowings hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Indebtedness</u>. As of the Effective Date, the Borrower and its Subsidiaries shall not have outstanding Indebtedness for borrowed money or preferred stock other than (i) Indebtedness under the Loan Documents, (ii) Indebtedness permitted under the Agreement, and Indebtedness as set forth on Schedule 7.2 of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Documentation</u>. The Lenders shall have received such other documents and other instruments or certificates as they may reasonably request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Material Adverse Effect</u>. Since June 30, 2022, there has been no development or event which has had or would reasonably be expected to have a Material Adverse Effect other than the Specified Event of Default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <u>Execution by Lenders</u>. This Amendment shall have been executed and delivered by each Lender hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. This Amendment is dated as of the date set forth in the first paragraph hereof and shall be effective (after satisfaction of the conditions set forth in Section 11 above) on the date of execution by the Agent and the Lenders, retroactive to such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. This Amendment shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. This Amendment may be executed in counterparts, each of which shall constitute an original, and each of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Amendment by PDF or other electronic means shall be effective as delivery of a manually executed original counterpart hereof. Notwithstanding the foregoing, the Borrower and Guarantors shall execute and deliver four (4) original counterparts of this Amendment to the Administrative Agent on or about the Effective Date.

*[Signature Page to Follow]*

 

<u>**SIGNATURE PAGE**</u>

IN **WITNESS WHEREOF,** the parties hereto have caused this Amendment to be duly executed and delivered by their respective duly authorized officers as of the date first above written.

---

| | |
|:---|:---|
| CPI AEROSTRUCTURES, INC., | CPI AEROSTRUCTURES, INC., |
| as Borrower | as Borrower |
| By: | /s/ Dorith Hakim |
|  | Dorith Hakim |
|  | Chief Executive Officer and President |
| BANKUNITED, N.A., | BANKUNITED, N.A., |
| as Arranger, Agent and a Lender | as Arranger, Agent and a Lender |
| By: | /s/ Jackie Garuz |
|  | Jackie Garuz |
|  | Special Assets Manager |
| BANKUNITED, N.A., | BANKUNITED, N.A., |
| as Administrative Agent and Collateral Agent | as Administrative Agent and Collateral Agent |
| By: | /s/ Jackie Garuz |
|  | Jackie Garuz |
|  | Special Assets Manager |
| DIME COMMUNITY BANK, | DIME COMMUNITY BANK, |
| as a Lender | as a Lender |
| By: | /s/ JoAnn Bello |
|  | JoAnn Bello |
|  | Senior Vice President |

---

*Signature Page to Waiver and Sixteenth Amendment to Amended and Restated Credit Agreement*

Each of the Guarantors indicated below hereby consent to this Amendment and acknowledge its continuing liability under its respective Guaranty with respect to the Agreement , as amended hereby , including (without limitation) the Loan Documents executed in connection with the Obligations and all other documents, instruments and agreements executed pursuant thereto or in connection therewith, without offset, defense of counterclaim, any such offset, defense or counterclaim as may exist being hereby irrevocably waived by each Guarantor.

---

| | |
|:---|:---|
| GUARANTORS: | GUARANTORS: |
| WELDING METALLURGY, INC. | WELDING METALLURGY, INC. |
| By: | /s/ Dorith Hakim |
|  | Dorith Hakim |
|  | Chief Executive Officer and President |
| COMPAC DEVELOPMENT CORPORATION | COMPAC DEVELOPMENT CORPORATION |
| By: | /s/ Dorith Hakim |
|  | Dorith Hakim |
|  | Chief Executive Officer and President |

---

*Guarantor Consent to Waiver and Sixteenth Amendment to Amended and Restated Credit Agreement*

## Exhibit 31.1

**[CPI AEROSTRUCTURES, INC. 10-Q](cpi-10q_093025.htm)**

**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Dorith Hakim, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this Quarterly Report on Form 10-Q of CPI Aerostructures, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
 to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
 material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
 presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and
 procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
 in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
 us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
 our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
 statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
 about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
 on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 third fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
 control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control
 over financial reporting, to the registrant's auditors and to the audit committee of the registrant's board of
 directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
 are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial
 information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: November 13, 2025 | CPI AEROSTRUCTURES, INC. | CPI AEROSTRUCTURES, INC. |
|  | (Registrant) | (Registrant) |
|  | By: | /s/ Dorith Hakim |
|  |  | Dorith Hakim |
|  |  | Chief Executive Officer, President and Director |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.2

**[CPI AEROSTRUCTURES, INC. 10-Q](cpi-10q_093025.htm)**

**EXHIBIT 31.2**

**CERTIFICATION PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Pamela Levesque, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this Quarterly Report on Form 10-Q of CPI Aerostructures, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
 to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
 material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
 presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and
 procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
 in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
 us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
 our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
 statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
 about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
 on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 third fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
 control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control
 over financial reporting, to the registrant's auditors and to the audit committee of the registrant's board of
 directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
 are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial
 information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: November 13, 2025 | CPI AEROSTRUCTURES, INC. | CPI AEROSTRUCTURES, INC. |
|  | (Registrant) | (Registrant) |
|  | By: | /s/ Pamela Levesque |
|  |  | Pamela Levesque |
|  |  | Interim Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**[CPI AEROSTRUCTURES, INC. 10-Q](cpi-10q_093025.htm)**

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**<br> **18 U.S.C. SECTION 1350**<br> **AS ADOPTED PURSUANT TO**<br> **SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of CPI Aerostructures, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission (the "Report"), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The
 Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The
 information contained in the Report fairly presents, in all material respects, the financial condition and results of operation
 of the Company.

---

| | | |
|:---|:---|:---|
| Dated: November 13, 2025 | CPI AEROSTRUCTURES, INC. | CPI AEROSTRUCTURES, INC. |
|  | (Registrant) | (Registrant) |
|  | By: | /s/ Dorith Hakim |
|  |  | Dorith Hakim |
|  |  | Chief Executive Officer, President and Director |
|  |  | (Principal executive officer) |
| Dated: November 13, 2025 | CPI AEROSTRUCTURES, INC. | CPI AEROSTRUCTURES, INC. |
|  | (Registrant) | (Registrant) |
|  | By: | /s/ Pamela Levesque |
|  |  | Pamela Levesque |
|  |  | Interim Chief Financial Officer and Secretary |
|  |  | (Principal financial and accounting officer) |

---